Innoviva Inc (INVA)

10.56 -0.23  -2.13% NASDAQ Nov 25, 20:00 USD
View Full Chart
Price Chart
View All Events


Date Type Description
02/05/2021 Earnings Innoviva Inc Fourth Quarter Earnings Results for 2020
10/28/2020 Earnings Innoviva Inc Third Quarter Earnings Results for 2020
07/29/2020 Earnings Innoviva Inc Second Quarter Earnings Results for 2020
04/29/2020 Earnings Innoviva Inc First Quarter Earnings Results for 2020
04/24/2020 Misc Innoviva Inc Annual General Meeting for 2019
02/21/2020 Misc Innoviva Inc Annual Report for 2019
02/05/2020 Earnings Innoviva Inc Fourth Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 05, 2021
  • Last Earnings Release: Oct. 28, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Sep. 08, 2015
  • Description: Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes RELVAR/BREO/ELLIPTA, ANORO, ELLIPTA, TRELEGY, ELLIPTA, and others. The firm collaborates with and receives funding from GlaxoSmithKline.

Top Fund Holders

Symbol Name Weighting
F000015PTS FT Automated Quantitative Analysis 21 CA 4.37%
F00001473A FT Automated Quantitative Analysis 19FCA 4.06%
JASCX James Small Cap 3.04%
F000014U9I FT Automated Quantitative Analysis 20FCA 2.94%
PJP Invesco Dynamic Pharmaceuticals ETF 2.53%
DDDCX 13D Activist C 1.98%
JSML Janus Henderson Small Cap Gr Alpha ETF 1.75%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.